Sientra Inc (NASDAQ:SIEN) has been given a consensus rating of “Buy” by the twelve brokerages that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, ten have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $24.14.

SIEN has been the topic of a number of recent research reports. BidaskClub downgraded shares of Sientra from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 31st. Dougherty & Co initiated coverage on shares of Sientra in a report on Thursday, August 30th. They issued a “buy” rating and a $31.00 price objective on the stock. Zacks Investment Research downgraded shares of Sientra from a “hold” rating to a “sell” rating in a report on Friday, September 21st. Stifel Nicolaus raised their target price on shares of Sientra from $21.00 to $25.00 and gave the company a “buy” rating in a research note on Wednesday, August 8th. Finally, Stephens reissued a “buy” rating and issued a $30.00 target price on shares of Sientra in a research note on Thursday, August 9th.

In related news, CEO Jeffrey M. Nugent sold 1,852 shares of the firm’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $24.90, for a total value of $46,114.80. Following the completion of the transaction, the chief executive officer now directly owns 297,999 shares of the company’s stock, valued at $7,420,175.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 31.00% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in SIEN. Janus Henderson Group PLC bought a new position in shares of Sientra in the second quarter valued at $20,375,000. Waddell & Reed Financial Inc. bought a new position in Sientra during the second quarter worth $15,035,000. BlackRock Inc. boosted its position in Sientra by 94.3% during the second quarter. BlackRock Inc. now owns 1,490,587 shares of the medical instruments supplier’s stock worth $29,081,000 after purchasing an additional 723,279 shares during the period. Millennium Management LLC bought a new position in Sientra during the first quarter worth $4,287,000. Finally, Columbus Circle Investors bought a new position in Sientra during the second quarter worth $8,507,000. 89.22% of the stock is owned by institutional investors and hedge funds.

NASDAQ SIEN opened at $24.09 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.63 and a current ratio of 3.06. Sientra has a 12-month low of $8.79 and a 12-month high of $26.79. The company has a market capitalization of $678.85 million, a PE ratio of -8.54 and a beta of -0.78.

Sientra (NASDAQ:SIEN) last posted its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported ($0.73) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.69) by ($0.04). Sientra had a negative net margin of 131.16% and a negative return on equity of 151.47%. The business had revenue of $17.55 million during the quarter, compared to analyst estimates of $15.30 million. On average, analysts predict that Sientra will post -2.93 EPS for the current fiscal year.

Sientra Company Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

See Also: Why Dividend Stocks May Be Right for You

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.